Shares in North Sea-focused oil company Enquest (LSE: ENQ) rose by nearly 8% this morning, despite yesterdays slide in oil prices.
The firms gains were driven by a bullish trading update. Production for the second half of the year rose by 26% to 35,022 barrels of oil equivalent per day (boepd), compared to the same period last year.
Production has continued to rise over the last three months, averaging 41,360 boepd between July and November. The gains are being driven by Enquests Alma and Galia fields, which have added 13,000 boepd to the firms production since the end of October.
What about costs?
Enquest expects to achieve an average operating cost of $26-$28 per barrel in 2016. The firm also has 10m barrels of hedging in place for next year at $65/bbl. Thats equivalent to about 27,000 boepd, and should make a significant difference to cash flow.
Offsetting this is the firms net debt, which is expected to total $1.55bn by the end of 2015.
Although the firm does not expect to have to start repaying debt until 2017, interest costs are rising and totalled $21.5m during the first half of this year.
While I am fairly sure that Enquest will be able to stay on top of its debt commitments, Im not sure whether there will be enough surplus cash to lift the share price or fund any dividends over the next few years.
Personally, I think its a little too soon to buy into Enquests recovery. I dont feel that theres much visibility of cash flow beyond 2016.
Tullow Oil
Its a similar story at Tullow Oil (LSE: TLW), but there are some differences.
Tullow trades on a price/book ratio of 0.6, compared to 0.2 for Enquest. In my view this suggests that the market is more confident in the future value of Tullows shares than those of Enquest.
Tullow also has a stronger hedging profile, with around half of current production hedged at $75/bbl for 2016 and a significant amount hedged at $73/bbl for 2017. Tullow is probably a safer buy than Enquest, but I still think that shareholders are likely to see poor returns over the next few years as Tullow focuses on reducing its debt levels.
Premier Oil
Two years ago, Premier Oil (LSE: PMO) took the bold step of buying into Rockhopper Explorations Sea Lion discovery in the Falkland Islands.
Plans for developing Sea Lion have been in the pipeline since then, but Premier hasnt been in any rush. Thats hardly a surprise, given the oil price crash. In my view, there is zero chance of this development happening until the market improves.
One reason for this is that Premiers balance sheet looks increasingly stretched by the firms debt.
Premier shares currently trade on just 0.3 times their book value. In my view this indicates that the market recognises that the demands of Premiers $2.3bn net debt are likely to take priority over shareholder returns when the oil market does start to improve.
Like the other two firms, Premier is in the middle of two big developments. Although production is ahead of guidance this year, broker forecasts for the firms 2015 earnings have been slashed by 30% over the last three months alone.
In my view, its too early to buy back into Premier.
Indeed, I’m not sure the oil industry as a whole has bottomed out just yet.
For investors looking for a mix of income and capital gains I think other sectors, such as pharmaceuticals, offer better prospects.
On firm that has caught my eye recently is the small-cap pharma stock featured in “1 Top Small-Cap Stock From The Motley Fool“.
The Fool’s top experts believe this company may currently be significantly undervalued as it targets a potential 4bn market with a new range of products.
To learn more, download this FREE, no-obligation report today.
Roland Head has no position in any shares mentioned. The Motley Fool UK has recommended Tullow Oil. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.